Certified by Founder Lodge 
                                        
                                        Nuclera
 
                                                 United Kingdom  -  Cambridge, Cambridgeshire 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $75,000,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                
2013
 - 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            At Nuclera, our mission is to better human health by making proteins accessible.  We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow r
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| October, 17 ,2024 | Unknown | $75,000,000 | 
                                                
 Verve Ventures
                                                                                
                                                                            
 British Patient Capital
                                                                                
 Cambridge Innovation Capital
                                                                                
 Patient Square Capital
                                                                                
                                                                            
 Elevage Medical Technologies
                                                                                
                                                                            
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
 
                                            
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)